CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($) $ in Thousands	Total	Business combination and PIPE [Member]	Previously Reported [Member]	Revision of Prior Period, Adjustment [Member]	Convertible Preferred Stock [Member]	Convertible Preferred Stock [Member] Previously Reported [Member]	Convertible Preferred Stock [Member] Revision of Prior Period, Adjustment [Member]	Common Stock [Member]	Common Stock [Member] Business combination and PIPE [Member]	Common Stock [Member] Previously Reported [Member]	Common Stock [Member] Revision of Prior Period, Adjustment [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Business combination and PIPE [Member]	Additional Paid-in Capital [Member] Previously Reported [Member]	Additional Paid-in Capital [Member] Revision of Prior Period, Adjustment [Member]	Accumulated Other Comprehensive loss	Accumulated Deficit [Member]	Accumulated Deficit [Member] Previously Reported [Member]
Beginning balance at Dec. 31, 2020						$ 79,204	$ (79,204)
Beginning balance, Shares at Dec. 31, 2020						8,606,780	(8,606,780)
Beginning balance at Dec. 31, 2020	$ 26,913		$ (52,291)	$ 79,204				$ 15		$ 9	$ 6	$ 87,982		$ 8,784	$ 79,198		$ (61,084)	$ (61,084)
Beginning balance, Shares at Dec. 31, 2020								151,365,509		8,069,693	143,295,816
Share-based compensation	4,513											4,513
Issuance of common stock upon exercise of stock options	198											198
Issuance of common stock upon exercise of stock options, Shares								701,139
Business combination and PIPE financing, net of acquired private placement warrant		$ 557,763							$ 6				$ 557,757
Business combination and PIPE financing, net of acquired private placement warrant, Shares									59,343,104
Offering cost in connection with Business combination and PIPE financing		(47,983)											(47,983)
Issuance of common stock upon release of restricted stock units, Shares								41,408
Unrealized loss on available-for-sale securities	(29)															$ (29)
Net loss	(19,458)																(19,458)
Ending balance at Mar. 31, 2021	521,917							$ 21				602,467				(29)	(80,542)
Ending balance, Shares at Mar. 31, 2021								211,451,160
Beginning balance at Dec. 31, 2020						$ 79,204	$ (79,204)
Beginning balance, Shares at Dec. 31, 2020						8,606,780	(8,606,780)
Beginning balance at Dec. 31, 2020	26,913		$ (52,291)	$ 79,204				$ 15		$ 9	$ 6	87,982		$ 8,784	$ 79,198		(61,084)	$ (61,084)
Beginning balance, Shares at Dec. 31, 2020								151,365,509		8,069,693	143,295,816
Unrealized loss on available-for-sale securities	(140)
Net loss	(43,531)
Ending balance at Jun. 30, 2021	502,179							$ 21				606,913				(140)	(104,615)
Ending balance, Shares at Jun. 30, 2021								211,961,741
Beginning balance at Mar. 31, 2021	521,917							$ 21				602,467				(29)	(80,542)
Beginning balance, Shares at Mar. 31, 2021								211,451,160
Share-based compensation	4,009											4,009
Issuance of common stock upon exercise of stock options	162											162
Issuance of common stock upon exercise of stock options, Shares								507,745
Offering cost in connection with Business combination and PIPE financing		$ 275											$ 275
Issuance of common stock upon release of restricted stock units, Shares								2,836
Unrealized loss on available-for-sale securities	(111)															(111)
Net loss	(24,073)																(24,073)
Ending balance at Jun. 30, 2021	502,179							$ 21				606,913				(140)	(104,615)
Ending balance, Shares at Jun. 30, 2021								211,961,741
Beginning balance, Shares at Dec. 31, 2021					0
Beginning balance at Dec. 31, 2021	456,376							$ 21				619,841				(524)	(162,962)
Beginning balance, Shares at Dec. 31, 2021								214,997,014
Share-based compensation	5,784											5,784
Issuance of common stock upon exercise of stock options	186							$ 1				185
Issuance of common stock upon exercise of stock options, Shares								1,029,266
Issuance of common stock upon release of restricted stock units, Shares								671,621
Shares withheld for the withholding tax on vesting of restricted stock	(244)											(244)
Shares withheld for the withholding tax on vesting of restricted stock, Shares								(53,553)
Issuance of common stock upon exercise of warrants	1											1
Issuance of common stock upon exercise of warrants, shares								120
Unrealized loss on available-for-sale securities	(2,455)															(2,455)
Net loss	(33,157)																(33,157)
Ending balance at Mar. 31, 2022	426,491							$ 22				625,567				(2,979)	(196,119)
Ending balance, Shares at Mar. 31, 2022								216,644,468
Beginning balance, Shares at Dec. 31, 2021					0
Beginning balance at Dec. 31, 2021	$ 456,376							$ 21				619,841				(524)	(162,962)
Beginning balance, Shares at Dec. 31, 2021								214,997,014
Issuance of common stock upon exercise of stock options, Shares	1,199,321
Unrealized loss on available-for-sale securities	$ (3,405)
Net loss	(68,128)
Ending balance, Shares at Jun. 30, 2022					0
Ending balance at Jun. 30, 2022	396,888							$ 22				631,885				(3,929)	(231,090)
Ending balance, Shares at Jun. 30, 2022								217,212,406
Beginning balance at Mar. 31, 2022	426,491							$ 22				625,567				(2,979)	(196,119)
Beginning balance, Shares at Mar. 31, 2022								216,644,468
Share-based compensation	6,434											6,434
Issuance of common stock upon exercise of stock options	58											58
Issuance of common stock upon exercise of stock options, Shares								170,055
Issuance of common stock upon release of restricted stock units, Shares								458,399
Shares withheld for the withholding tax on vesting of restricted stock	(174)											(174)
Shares withheld for the withholding tax on vesting of restricted stock, Shares								60,516
Unrealized loss on available-for-sale securities	(950)															(950)
Net loss	(34,971)																(34,971)
Ending balance, Shares at Jun. 30, 2022					0
Ending balance at Jun. 30, 2022	$ 396,888							$ 22				$ 631,885				$ (3,929)	$ (231,090)
Ending balance, Shares at Jun. 30, 2022								217,212,406